Detalhe da pesquisa
1.
Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis.
Clin Gastroenterol Hepatol
; 18(10): 2295-2304.e2, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32068151
2.
Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases.
Clin Gastroenterol Hepatol
; 18(1): 179-187.e6, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31100458
3.
Obeticholic acid-a new therapy in PBC and NASH.
Br Med Bull
; 133(1): 95-104, 2020 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32282030
4.
Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring System.
Hepatology
; 69(5): 2120-2135, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30566748
5.
Prevalence and long-term outcome of sub-clinical primary sclerosing cholangitis in patients with ulcerative colitis.
Liver Int
; 40(11): 2744-2757, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32841490
6.
A novel prognostic model for transplant-free survival in primary sclerosing cholangitis.
Gut
; 67(10): 1864-1869, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28739581
7.
Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort study.
Hepatology
; 65(3): 907-919, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27880989
8.
Surrogate endpoints for clinical trials in primary sclerosing cholangitis: Review and results from an International PSC Study Group consensus process.
Hepatology
; 63(4): 1357-67, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26418478
9.
Immunoglobulin G4(+) B-cell receptor clones distinguish immunoglobulin G 4-related disease from primary sclerosing cholangitis and biliary/pancreatic malignancies.
Hepatology
; 64(2): 501-7, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27015613
10.
New Therapeutic Strategies for Primary Sclerosing Cholangitis.
Semin Liver Dis
; 36(1): 5-14, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26870928
11.
Elevated Serum IgG4 Levels in Diagnosis, Treatment Response, Organ Involvement, and Relapse in a Prospective IgG4-Related Disease UK Cohort.
Am J Gastroenterol
; 111(5): 733-43, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27091321
12.
Primary sclerosing cholangitis: a clinical update.
Br Med Bull
; 114(1): 53-64, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25981516
13.
Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis.
Hepatology
; 59(5): 1954-63, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24375491
14.
The genetics of complex cholestatic disorders.
Gastroenterology
; 144(7): 1357-74, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23583734
15.
Primary sclerosing cholangitis.
Dig Dis
; 32(4): 438-45, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24969292
16.
Improvement of serum alkaline phosphatase to <1.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitis.
J Hepatol
; 58(2): 329-34, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23085647
17.
Risk for colorectal neoplasia in patients with colonic Crohn's disease and concomitant primary sclerosing cholangitis.
Clin Gastroenterol Hepatol
; 10(3): 303-8, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22037429
18.
Cholangiocarcinoma complicating secondary sclerosing cholangitis from cryptosporidiosis in an adult patient with CD40 ligand deficiency: case report and review of the literature.
Int Arch Allergy Immunol
; 159(2): 204-8, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22678466
19.
Fine mapping and replication of genetic risk loci in primary sclerosing cholangitis.
Scand J Gastroenterol
; 47(7): 820-6, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22554193
20.
Primary sclerosing cholangitis: is any treatment worthwhile?
Curr Gastroenterol Rep
; 14(1): 17-24, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22124849